Spinal implants, bone growth therapies, and limb reconstruction for orthopedic surgery
Orthofix manufactures spinal hardware, bone growth devices, biologics, and the 7D FLASH navigation system for orthopedic and spine surgery. The tech stack reflects a hardware-focused business: CAD tools (Creo, SolidWorks), embedded systems (C, C++, .NET), and enterprise infrastructure (Oracle, SAP, Salesforce, SQL Server). Active hiring skews toward sales and engineering across North America and Europe, with a heavy project focus on novel spinal implant development and clinical adoption—signaling continued product innovation alongside a strategic shift toward payer relationships.
Orthofix is a publicly traded medical technology company headquartered in Lewisville, Texas, operating across 1,001–5,000 employees globally. The company develops and markets orthopedic solutions including spinal fixation systems, bone growth therapies (BioStim), biologics for bone fusion, limb reconstruction products, and intraoperative navigation technology. Orthofix sells to hospitals, surgical centers, and orthopedic practices, with distribution partners and direct relationships in the United States, Europe, and Canada. Current operational priorities include expanding spinal implant portfolio, training surgeon adoption, and navigating a structural shift in healthcare contracting away from physician preference toward payer procurement.
Orthofix manufactures spinal fixation systems, bone growth therapies (BioStim), biologics for bone fusion, limb reconstruction products, and the 7D FLASH intraoperative navigation system for orthopedic and spine surgery.
Orthofix is headquartered in Lewisville, Texas, and operates as a publicly traded company with 1,001–5,000 employees globally.
Other companies in the same industry, closest in size